Quantcast

Latest Valvular heart disease Stories

2014-07-29 23:04:40

Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver, BC (PRWEB) July 29, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the Global Cardiac Surgery Devices Market will grow to over $8 billion by 2018. This growth will be fueled by extensive technological...

2014-07-14 23:02:06

Comprehensive study “European Market for Cardiac Surgery Devices 2014” worked out by iData Research is now available at MarketPublishers.com. According to the report, Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020. London, UK (PRWEB) July 14, 2014 Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020, with the transcatheter heart valve devices sector (composed of the transcatheter heart...

2014-07-14 20:21:24

European Launch Means Physicians Can Now Choose From Three Available Valve Sizes To Match Patient Anatomy More Precisely MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European commercial launch of its new 25 mm Lotus(TM) Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes. "Having the 25 mm size allows us to be more precise in selecting the...

2014-07-03 23:03:47

GIA announces the release of a comprehensive global report on Prosthetic Heart Valves. Global market for Prosthetic Heart Valves is projected to reach US$4.8 billion by 2020, driven by aging population & increasing prevalence of cardiovascular disorders, growing adoption of bioprosthetic/tissue heart valves, and regulatory clearance of Transcatheter Aortic Valve Implantation (TAVI) in major markets. San Jose, California (PRWEB) July 03, 2014 Follow us on LinkedIn. – Prosthetic heart...

2014-06-16 20:21:59

FDA Approval Includes High-Risk and Inoperable Indications, Transfemoral and Alternative Access Systems IRVINE, Calif., June 16, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received United States Food and Drug Administration (FDA) approval for its Edwards SAPIEN XT transcatheter aortic heart valve for the treatment of high-risk and inoperable patients...

2014-06-11 20:22:36

New Interactive Campaign Offers Information and Education WASHINGTON, June 11, 2014 /PRNewswire-USNewswire/ -- A new campaign from the Alliance for Aging Research aims to raise awareness about the effects of aortic stenosis, a disease caused by the gradual buildup of calcium deposits in the aortic valve. It affects more than 1.5 million Americans. If left untreated, aortic stenosis can lead to fainting, chest pain, fatigue and, in worst case scenarios, death. This interactive, multimedia...

2014-06-11 08:29:37

Trendlines Medical and two portfolio companies of The Trendlines Group keep Trendlines on its award-winning path TEL AVIV, Israel, June 11, 2014 /PRNewswire/ -- Trendlines Medical [http://trendlines.com/medical ] received the Best Incubator award and two Trendlines portfolio companies received Best Start-up of the Year - Advanced Mem-Tech (Trendlines Agtech [http://trendlines.com/agtech ]) and MitrAssist (Trendlines Medical) - from Israel's Office of the Chief Scientist of the...

2014-06-05 00:21:14

NATICK, Mass., June 4, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the RESPOND Post Market Registry to assess real world performance of the Lotus(TM) Valve System. The RESPOND Registry will collect data on clinical outcomes and device performance in 1,000 patients implanted at 50 centers around the world. Three patients enrolled in the RESPOND Registry thus far have been successfully implanted with the Lotus Valve System. Dr. Nicolas Van Mieghem and...

2014-05-12 23:06:30

Revolutionizing developments in biological tissue vales will drive the European transcatheter heart valve implantation market to over $1.7 Billion by 2020, Reports iData Research Vancouver, BC (PRWEB) May 12, 2014 According to a new report on the European Market for Cardiac Surgery Devices by iData Research (http://www.idataresearch.com), the leading global authority in medical device and pharmaceutical market research, the total European Cardiac Surgery Devices market is projected to...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related